Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel Yamshon

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Clinical Advances in Hematology & Oncology : H&O|June 9, 2021
Are novel agents ready to assume the mantle in the frontline treatment of mantle cell lymphoma?Samuel Yamshon, Peter Martin
BMJ Case Reports|September 2, 2018
Disseminated tuberculosis masquerading as a neuroendocrine tumourRuslan Garcia, Samuel Yamshon
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 25, 2025
Double trouble: Non-relapse mortality with bispecific antibodies in lymphoma and myelomaRahul Banerjee, Samuel Yamshon
Current Hematologic Malignancy Reports|July 15, 2019
IMiDs New and OldSamuel Yamshon, Jia Ruan
Leukemia & Lymphoma|July 13, 2022
Real world CAR T cell data in diffuse large B-cell lymphoma: hitting a moving targetSamuel Yamshon, Hsu Jing-Mei
Journal of the National Cancer Institute|September 19, 2025
Unstacking the deck in follicular lymphoma clinical trialsSamuel Yamshon, John P Leonard
Leukemia & Lymphoma|April 28, 2020
An update on options of therapy for aggressive mantle cell lymphomaJia Ruan, Samuel Yamshon, Koen van Besien, et al.
Trends in Cancer|July 10, 2024
Current landscape of CD3 bispecific antibodies in hematologic malignanciesJoshua Kassner, Basma Abdellatif, Samuel Yamshon, et al.
Blood Advances|June 24, 2018
Venous thromboembolism in patients with B-cell non-Hodgkin lymphoma treated with lenalidomide: a systematic review and meta-analysisSamuel Yamshon, Paul J Christos, Michelle Demetres, et al.
Frontiers in Cell and Developmental Biology|January 24, 2022
Epigenetic, Metabolic, and Immune Crosstalk in Germinal-Center-Derived B-Cell Lymphomas: Unveiling New Vulnerabilities for Rational Combination TherapiesInna Serganova, Sanjukta Chakraborty, Samuel Yamshon, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Clinical Advances in Hematology & Oncology : H&O|June 9, 2021
Are novel agents ready to assume the mantle in the frontline treatment of mantle cell lymphoma?Samuel Yamshon, Peter Martin
BMJ Case Reports|September 2, 2018
Disseminated tuberculosis masquerading as a neuroendocrine tumourRuslan Garcia, Samuel Yamshon
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 25, 2025
Double trouble: Non-relapse mortality with bispecific antibodies in lymphoma and myelomaRahul Banerjee, Samuel Yamshon
Current Hematologic Malignancy Reports|July 15, 2019
IMiDs New and OldSamuel Yamshon, Jia Ruan
Leukemia & Lymphoma|July 13, 2022
Real world CAR T cell data in diffuse large B-cell lymphoma: hitting a moving targetSamuel Yamshon, Hsu Jing-Mei
Journal of the National Cancer Institute|September 19, 2025
Unstacking the deck in follicular lymphoma clinical trialsSamuel Yamshon, John P Leonard
Leukemia & Lymphoma|April 28, 2020
An update on options of therapy for aggressive mantle cell lymphomaJia Ruan, Samuel Yamshon, Koen van Besien, et al.
Trends in Cancer|July 10, 2024
Current landscape of CD3 bispecific antibodies in hematologic malignanciesJoshua Kassner, Basma Abdellatif, Samuel Yamshon, et al.
Blood Advances|June 24, 2018
Venous thromboembolism in patients with B-cell non-Hodgkin lymphoma treated with lenalidomide: a systematic review and meta-analysisSamuel Yamshon, Paul J Christos, Michelle Demetres, et al.
Frontiers in Cell and Developmental Biology|January 24, 2022
Epigenetic, Metabolic, and Immune Crosstalk in Germinal-Center-Derived B-Cell Lymphomas: Unveiling New Vulnerabilities for Rational Combination TherapiesInna Serganova, Sanjukta Chakraborty, Samuel Yamshon, et al.
Pageof 4